Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen +3 more
wiley +1 more source
Molecular Mechanisms and Clinical Evidence Supporting the Four Pillars of Therapy in Diabetic Kidney Disease: Emerging Therapeutic Perspectives. [PDF]
Yanai H +3 more
europepmc +1 more source
In this territory‐wide cohort study, improving glycemic control can be observed regardless of cirrhosis status. Oral antidiabetic medication was more often used in the non‐cirrhosis group, and insulin was preferred in patients with decompensated cirrhosis, who exhibited an increasing incidence of hypoglycemia over the years and need individualized ...
Mary Yue Wang +6 more
wiley +1 more source
The Involvement of the Peptidergic Systems in Breast Cancer Development. [PDF]
Sánchez ML +5 more
europepmc +1 more source
The potential for biased signalling in the P2Y receptor family of GPCRs
The purinergic receptor family is primarily activated by nucleotides, and contains members of both the G protein coupled‐receptor (GPCR) superfamily (P1 and P2Y) and ligand‐gated ion channels (P2X). The P2Y receptors are widely expressed in the human body, and given the ubiquitous nature of nucleotides, purinergic signalling is involved with a plethora
Claudia M. Sisk +2 more
wiley +1 more source
Treatment gaps in guideline-directed medical therapy for HFrEF in Singapore: findings from a multicentre retrospective cohort study. [PDF]
Senanayake S +14 more
europepmc +1 more source
Improving Heart Failure Quality of Care Over the First Twenty Years: The Get With The Guidelines-Heart Failure Program. [PDF]
Tang AB +14 more
europepmc +1 more source
Pharmacological Effects of Angiotensin 1-7 on Venous Vascular Tone. [PDF]
Daci A +5 more
europepmc +1 more source
Landscape of diabetic kidney disease drug clinical trials in China (2013-2023): global implications for innovation and policy. [PDF]
Yang Y +5 more
europepmc +1 more source

